Business Tutorial: DxRx Summit—Nucleic Acid Diagnostics & Therapeutics
May 13, 2009 – 1:00pm to 5:00pm (Hilton Boston Logan Airport, Boston, MA, USA)
Presented by Enal Razvi, PhD
This business tutorial will take place on the final afternoon of the DxRx Summit. The conference delegate pass includes admission to the tutorial. If you would like to attend only the tutorial (or a tutorial + report package) you can register separately for it here. The tutorial provides a focused presentation and analysis of the market and business trends in the broader nucleic acid diagnostics and therapeutics spaces.
The scope of industry coverage presented in this tutorial is in line with the broader topics covered at this conference and these are areas which Select Biosciences continually covers in its industry research and published market reports.
Areas Addressed in this Business Tutorial:
- Qualitative and quantitative trends and market metrics in the cancer personalized medicine marketplace. The focus here is on nucleic acid-based tests—especially the IVDMIAs—that are being developed and commercialized for cancer personalized medicine, the leading edge marketplace for the deployment of nucleic acid-based tests
- MicroRNA-based diagnostics and therapeutics. This is an emerging area and Select Biosciences has been covering these markets comprehensively—especially the development and use of microRNA as biomarkers as well as the emerging theme of using microRNAs as therapeutic targets
- Epigenetics—The therapeutic targeting of cancers and other diseases by addressing chromatin and its modification (especially through HDAC enzymes and other elements of the chromatin make-up).
For more information please click here